Lipoprotein lipase (LPL), the rate limiting enzyme for hydrolysis of lipoprotein triglyceride, also mediates nonenzymatic interactions between lipoproteins and heparan sulfate proteoglycans. To determine whether cell surface LPL increases LDL binding to cells, bovine milk LPL was added to upregulated and nonupregulated human fibroblasts along with media containing LDL. LDL binding to cells was increased 2-10-fold, in a dosedependent manner, by the addition of 0.5-10 gg/ml of LPL. 
Introduction
Lipoprotein lipase (LPL)' is the rate limiting enzyme for hydrolysis of triglyceride (TG) in circulating lipoproteins. Aside from this enzymatic action as a lipase, LPL may mediate several other biological processes. Uptake of emulsion cholesteryl ester by cultured fibroblasts and rat mesenchymal heart cells was increased after addition of LPL ( 1 ), prompting Stein et al. to postulate that LPL can function as a cholesterol transfer protein. Similarly, Traber et al. showed that uptake of vitamin E by fibroblasts was increased in the presence of LPL (2) . The LPL-mediated effect on vitamin E uptake was eliminated by heparin which dissociates LPL from cell surfaces. Therefore, these investigators concluded that the presence of LPL protein on the cell surface, rather than LPL enzymatic activity, was required for vitamin E uptake. More recently, Saxena et al. (3) in our laboratory showed that LPL increased LDL retention by subendothelial cell matrix. Because LPL has both lipid and heparin binding sites (4, 5) , we postulated that LPL can form a bridge between lipoproteins and heparan sulfate proteoglycans.
The classical LDL receptor pathway, and perhaps other receptor mediated pathways, are major mechanisms for cellular internalization oflipoproteins. Recent work, however, has suggested that TG-rich lipoproteins (6) , and perhaps other lipidcontaining particles (7) , may be taken up by receptor-independent pathways. Non-receptor mediated uptake mechanisms often involve absorptive endocytosis which, in some cases, follows initial attachment of lipoproteins to cell surfaces. If LPL, bound to cell surface heparan sulfate proteoglycans (8, 9) , enhances lipoprotein binding to cells, it might then modulate cellular uptake of those particles.
In the current studies we explored whether LPL affected the metabolism of LDL and lipid emulsions by normal fibroblasts, receptor negative fibroblasts, THP-1 monocytes, and THP-1 macrophages. THP-1 monocytes (derived from a human monocytic leukemia), when differentiated, express the LPL gene and secrete LPL ( 10, 1 1). Our data support the hypothesis that LPL potentiates the binding of LDL and emulsion particles to the cells, thereby increasing their cellular uptake and degradation. This process does not appear to involve classical lipoprotein receptor pathways. Our results suggest that, in certain environments where LPL is present in sufficient concentrations, LPL may enhance cellular uptake of lipoproteins.
Methods

Low density lipoproteins
Blood from normolipidemic subjects was collected into Vacutainer tubes (Becton Dickinson, Rutherford, NJ) containing EDTA (1 mg/ ml) and the plasma was separated by centrifugation at 2,000 rpm for 20 min. EDTA (1.2 g/liter), NaN3 (0.1 g/liter) and aprotinin ( 10,000 U/liter) (Sigma Chemical Co., St. Louis, MO) were added to the plasma ( 12) and LDL was isolated by sequential ultracentrifugation ( 1.019 g/ml < d < 1.063 g/ml) ( 13) . LDL was radioiodinated using established methods ( 14) and dialyzed extensively against saline ( 150 mM NaCl, 0.24 mM EDTA, pH 7.4) before use. Radioactivity was measured using a gamma counter (model 1274; LKB, Gaithersburg, after a 60-min incubation with 10% (vol/vol) trichloroacetic acid at40C.
Lipoprotein lipase LPL was purified from fresh bovine milk using heparin-Sepharose (Pharmacia LKB Biotechnology Inc., Piscataway, NJ) as described by Socorro et al. ( 15) , and stored at -70'C. Purified LPL was radioiodinated as described by Saxena et al. ( 16) and stored in the presence of 1% BSA (Sigma Chemical Co.) at -70'C. Purified LPL showed a single major protein band of -55 kD when analyzed by SDS-PAGE. The specific activity of labeled LPL ranged between 1,000 and 1,500 cpm/ ng. In some experiments a monoclonal antibody was used to block the lipid binding site ofLPL. Details ofantibody production and specificity have been described previously ( 17) .
Cells
Fibroblasts. Human (N I ) fibroblasts from the foreskin ofnormal newborns were plated from frozen stock (6th-12th passage) at a density of 2.7 x 104 cells/22-mm well. Using established methods (12) , cells were grown for 5 d in DMEM supplemented with 1% (vol/vol) glutamine, 1% (vol/vol) penicillin, 1% (vol/vol) streptomycin, and 10% (vol/vol) calf serum (Gibco Laboratories, Grand Island, NY). To increase the number of LDL receptors on the fibroblast surface, some cells were switched to medium containing 10% fetal bovine lipoprotein-deficient serum for two additional days before use. These cells are referred to as upregulated fibroblasts. Nonupregulated cells were grown exclusively in serum-containing medium. Lipoprotein-deficient serum was prepared by ultracentrifugation ofthe serum at d = 1.25 g/ml and removal of the lipoprotein-containing supernatant.
LDL receptor-negative fibroblasts (GM2000; Coriell, Camden, NJ) were plated at a density of8 x I05 cells/22-mm well and grown for 10 days in DMEM similar to that described above except that calf serum was replaced with 20% fetal bovine serum. These cells have < 1% of the LDL binding capacity of normal fibroblasts.
Monocytes. THP-1 cells were purchased from the American Type Culture Collection (Rockville, MD) and grown in RPMI 1640 (Gibco Laboratories) containing 10% fetal calf serum as described by Auwerx et al. ( 18) . The medium was changed every three days. Phorbol 12-myristate 13-acetate ( 1.6 x I0-7 M) (Sigma Chemical Co.) was used to differentiate THP-l cells into macrophages ( 19) and the cells were grown in RPMI 1640 containing 10% fetal calf serum, 10 -8 M insulin, and I0-7 M dexamethasone.
Cellular 4°C binding ofLDL and LPL
Binding of LDL to fibroblasts was measured after a 2.5-h incubation at 4°C in DMEM containing 25 mM Hepes (Sigma Chemical Co.), 1% BSA (wt/vol), pH 7.4, and 5 Mg/ml '25I-LDL. In the majority ofexperiments, LPL was added to cell media simultaneously with '25I-LDL. In a few experiments, LPL was "prebound" to cells during a 2-h, 4°C incubation in DMEM (1% BSA) containing 5 jig/ml LPL. These cells were subsequently washed and '251-LDL was added in fresh medium as described above. In either case, after the 2.5-h incubation, cells were washed five times with PBS (2.7 mM KCI, 137 mM NaCI, 1.5 mM KH2PO4, 8 mM Na2HPO4, 0.2 mM EDTA)-0.2% BSA and twice with PBS. The cells were removed from the plates by addition of 0.1 N NaOH and total radioactivity bound to the cells was determined. Cellular binding, uptake, and degradation ofLDL Cell surface bound, intracellular, and degraded LDL were assessed using nonupregulated fibroblasts. '251-LDL (5 Ag/ml) was bound to the cell surface in the presence or absence ofLPL ( 10 tig/ml) at4C for 2.5 h. The medium was removed and the cells washed three times with PBS-0.2% BSA to remove unbound LDL. Cells were then warmed to 370C and cell surface, intracellular, and degraded LDL were determined over time. Cell-surface LDL anchored by LPL was assessed by incubating the cells for 30 min at 4VC with PBS containing 100 U/ml heparin. Cells were subsequently incubated 1 h at 4VC with 1,400 U/ ml of heparin to remove any remaining LPL or LDL from the surface, washed once with PBS containing 0.2% BSA and twice with PBS, and dissolved in 0.1 N NaOH. This second heparin wash led to minimal additional LDL release. The radioactivity in the NaOH fraction represented the amount of intracellular LDL. LDL degradation was determined as the amount of trichloroacetic acid soluble, noniodine, radioactivity in the medium ( 12) . Parallel incubations in cell-free wells were performed to control for non-cell mediated LDL degradation.
Surface binding, uptake, and degradation of LDL were also studied in receptor-negative fibroblasts and THP-1 macrophages. Cells were incubated at 370C for 18 h with '251I-LDL (10 ug/ml for fibroblasts, 5
Mg/ml for macrophages) in 22-mm tissue culture plates, the LDL-containing media was removed, and cells were washed with 4°C buffers as described earlier. Cell surface (heparin-releasable), intracellular, and degraded LDL were determined as described above in the presence or absence of heparin (10 U/ml), anti-LPL monoclonal antibody (100 Mg/ml), or nonspecific anti-mouse IgG.
Lipid emulsions 50 mg of triolein (Nu-Check, Elysian, MN) was added to 50 mg of egg yolk phosphatidylcholine (Avanti Polar Lipids, Inc., Alabaster, AL) and the organic solvents completely evaporated under N2. 50 tCi of [3H]cholesteryl hexadecyl ether (New England Nuclear, Boston, MA) was added as a nondegradable neutral lipid marker. The dry lipids were resuspended in saline at 60°C with added sucrose ( 1 g/ 10 ml) and sonicated for 1 h at 55°C at 140 W under a stream of nitrogen using a Branson sonifier (model 450; Branson Ultrasonics Corp., Danbury, CT). After sonication, the solution was dialyzed overnight to remove sucrose, centrifuged for 20 min at 40,000 rpm, and the opaque middle fraction containing small emulsion particles removed (free ofphospholipid liposomes, which because of their trapped sucrose sink to the bottom ofthe infranate). This fraction was then spun at 28,000 rpm for 15 h, collected, and analyzed for TG and phospholipid content.
Cellular binding and uptake of TG emulsions
Nonupregulated fibroblasts were incubated for 5 or 22 h at 37°C with TG emulsions (200 Ag/mi TG/ml, TG/phospholipid ratio of 2.38), containing a nondegradable marker, [3H]cholesteryl ether (510 cpm/ jg TG) with or without LPL (10 Mg/ml) and heparin (10 U/ml).
After incubation, the cell media was removed and analyzed for TG hydrolysis and the cells were washed and treated as described above for LDL studies. Bound emulsion was considered the radioactivity released by a 30-min incubation with PBS containing heparin (100 U/ ml). Uptake was considered the amount of radioactivity remaining with the cells after an additional 60-min incubation with PBS containing heparin ( 1,400 U/ml) and further washing with PBS-BSA and PBS as described earlier.
THP-l macrophages were incubated for 18 h at 37°C with TG emulsion (200 Mg/ml, TG/phospholipid ratio of Using up to 30 1g of '251-LPL, 5-10% of the added LPL bound to the cell surface and was released by heparin-containing buffers. LPL binding was maximal after 60 min of incubation at 4VC (data not shown). Thus, LPL binds to a heparinsensitive site on the surface of cultured fibroblasts.
The ability ofcell surface bound LPL to enhance LDL binding was then assessed. Nonupregulated fibroblasts were incubated with LPL (5 ugg/ml) for 2 h at 4VC and the medium was then replaced with LPL-free medium containing '25I-LDL (prebound) . Other cells were incubated with medium containing both LPL and LDL (simultaneous addition). LDL binding to fibroblasts increased dramatically with either method of LPL addition. Compared to control cells incubated without LPL, cells with prebound LPL bound > 50-fold more LDL (Fig. 1 B) . Cells coincubated with the same amount of LPL and 251I-LDL bound > 75-fold more LDL than control cells. The somewhat lesser effect with prebound LPL may be the result of less LPL on the cell surface due to the additional washing step and dissociation of bound LPL into fresh, LPLfree media. Nonetheless, prebound LPL also markedly increased LDL binding to the fibroblasts.
Internalization and degradation ofcell surface boundLDL. LDL binding to the cell surface; the chondroitinase treatment had no effect (Fig. 3) anti-LPL monoclonal antibody. As shown in Fig. 4 (Fig. 5) . LPL-mediated emulsion binding was significantly greater at 5 h (13,999±374 cpm/mg cell protein) compared with 22 h (5,534±1,668 cpm/mg cell protein, P < 0.002). The opposite was true for cellular uptake which was less at 5 h (27,951±379 cpm/mg cell protein) than at 22 h (89,362±13,536 cpm/mg cell protein, P < 0.002). This suggested that, similar to studies with LDL, LPL-mediated uptake ofemulsion particles was a relatively slow process. Heparin (10 U/ml) completely inhibited the LPL-mediated uptake and binding of [3H] (Fig. 7 A) . Anti-LPL monoclonal antibody (100,ug/ml) reduced the LPL-mediated cell surface LDL binding by 61 % (P < 0.005), internalization by 68% (P < 0.0001), and degradation by 87% (P < 0.001). Therefore, even in THP-1 macrophages, additional LPL increased LDL metabolism. The effect ofadded LPL on cellular uptake ofTG emulsion paricles is shown in Fig. 7 by the addition of heparin or anti-LPL monoclonal antibody. Nonspecific (control) IgG had no inhibitory effect.
Role of endogenous LPL in THP-J macrophages. Since THP-1 macrophages secrete LPL, we asked whether LPL endogenously synthesized by macrophages modulated LDL and TG emulsion metabolism. To explore this, heparin ( 10 U/ml) was used to release endogenously produced LPL from the cell surface and anti-LPL monoclonal antibodies were used to inhibit LPL interaction with lipoproteins ( 17) . As shown in Fig.  8 A, during an 18-h incubation, heparin decreased LDL degradation by 41% (P < 0.05) and anti-LPL antibody decreased degradation by 49% (P < 0.02). Intracellular LDL was decreased comparable amounts. In an 18-h incubation with TG emulsion particles, heparin also decreased particle uptake by 59% (P < 0.0001) and anti-LPL monoclonal antibody decreased particle uptake by 69% (P < 0.0001 ). Thus, our data suggest that LPL synthesized by THP-1 macrophages was responsible for at least 40-50% of LDL uptake and degradation, and 60-70% of TG emulsion uptake by these cells. (28) which is present on fibroblasts (29), LRP-mediated uptake of ligands like a2-macroglobulin is much more rapid than LPL-mediated uptake (30) . Scavenger receptors are not present at significant levels in either fibroblasts or THP-1 monocytes (31, 10) . Therefore, neither of these lipoprotein receptors are likely to be involved in LPL-mediated binding, uptake, and degradation of LDL. It is also unlikely that our results were due to lipolysis ofLDL by LPL. The binding studies were performed at 4VC, a temperature at which LPL activity is very low. Furthermore, binding and uptake of TG emulsion particles was independent of TG hydrolysis. Finally, because LPL-mediated effects were blocked by anti-LPL monoclonal antibodies and heparin, it is unlikely that our results were due to a contaminant in the LPL preparation. LPL-mediated binding, uptake, and degradation of LDL and emulsion particles may require the internalization and degradation of cell surface heparan sulfate proteoglycans. Such a mechanism is illustrated in Fig. 9 and is supported by three observations. (a) Cell surface heparan sulfate proteoglycans are internalized and degraded with a half-life of -7 h by pigeon macrophages (32 Studies to determine the mechanisms of LPL-mediated LDL uptake were initially performed using fibroblasts; however, the physiological and pathophysiological implications of our studies are most relevant to cells having large amounts of surface LPL. These cells include endothelial cells and LPL synthesizing cells such as adipocytes (4), myocytes (4), hippocampal neurons (33) , and macrophages ( 34, 35) . We also studied monocytes and macrophages because of their relevance to the generation of atherosclerosis. THP-l cells synthesize LPL and, therefore, we could study the effect of both endogenously produced LPL and exogenously added LPL on LDL uptake and degradation. As discussed above, uptake and degradation of LDL by these macrophages were inhibited by (a) low concentrations of heparin, which do not dissociate LDL from the LDL receptor but are sufficient to release LPL from the cell surface; and (b) an anti-LPL monoclonal antibody. These data suggest that the ability of THP-l macrophages to metabolize LDL and lipid emulsions was, to a large degree, dependent on LPL synthesized by these cells.
Although TG-rich lipoproteins are the preferred substrate for LPL-mediated enzymatic actions, LPL associates with both LDL and VLDL. Kinetic studies by Deckelbaum et al. (36) showed that the affinity of LPL for LDL is similar to its affinity for VLDL. Since there are many more molecules ofLDL in the circulation of normal individuals, LPL primarily associates with LDL in normolipidemic plasma (25). In addition, because oftheir greater diameter, VLDL are less likely than LDL to cross the endothelial barrier into the interstitial fluid. Thus, LPL on the surface of vessel wall macrophages would have a greater opportunity to interact with LDL than with VLDL.
The effects of LPL on lipoprotein uptake by macrophages have been reported by other investigators. Lindqvist et al. (37) showed that LPL hydrolytic activity increased VLDL uptake by J774 macrophages. Some of this increase was undoubtedly due to interaction ofapo E on lipolyzed VLDL with cell surface receptors (38) . Using apo CII-deficient VLDL, however, Lindqvist et al. also noted lipolysis independent VLDL uptake. Therefore, some VLDL may have been internalized via the LPL-mediated processes described in our studies. The influence of LPL on LDL uptake by macrophages was studied by Aviram et al. (39) . These 
